[Question] incretin — what am I missing here
incretin — what am I missing here. I am not trying to be the "source?" guy. I would just like a source.
Was completely wrong about the gastric emptying story in a thread here two years ago. Someone corrected me with a citation and I have not made that mistake since.
The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.
Tried to build a mental model from mechanism alone and produced a confident prediction that the trial data flatly contradicted.
Sceptical readings welcome. The confident ones are the ones I distrust.
best — the order this archive was captured in
Tolerance to the gastric effect develops with continued exposure while the appetite effect largely persists. That single fact explains most of the "it settles but it still works" pattern the side-effect board reports.
Read the primary paper after arguing about the summary for a fortnight. The discussion section said almost the opposite of what the thread had concluded.
Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.
the central appetite effect is doing more work than the gut effect
Is that from a human study or a preclinical model?
Small fix — it slows gastric emptying, it does not halt it, and the distinction matters for the mechanism you are proposing.
GIP is the arm people argue about because the biology is genuinely unsettled
What does the discussion section say about the limitation you are glossing?
Yes. The central component is the one that explains the reports on this site better than gastric emptying does.
glucagon agonism sounds paradoxical until you read the energy expenditure work
Long half-life in this class comes from structural modification that promotes albumin binding and resists enzymatic degradation. Weekly dosing is a consequence of the molecule, not a convenience decision.